Captrust Financial Advisors Regeneron Pharmaceuticals, Inc. Transaction History
Captrust Financial Advisors
- $30.9 Billion
- Q2 2024
A detailed history of Captrust Financial Advisors transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 8,834 shares of REGN stock, worth $7.25 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
8,834
Previous 8,899
0.73%
Holding current value
$7.25 Million
Previous $8.57 Million
8.39%
% of portfolio
0.03%
Previous 0.03%
Shares
26 transactions
Others Institutions Holding REGN
# of Institutions
1,505Shares Held
85.3MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$7.38 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.93 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$6.15 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.84MShares$3.97 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$3.81 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $88B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...